Deck the halls with resignations: LianBio CEO, CFO out; CRISPR Therapeutics CMO to leave in January

Yizhe Wang

? On Dec. 16, Yizhe Wang turned in his resignation as CEO of LianBio, while board member and Perceptive chief investment officer Adam Stone will grab the reins on an interim basis. The C-suite overhaul…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks